- Home
- ABCL vs FOR Comparison
ABCL vs FOR Comparison
Compare ABCL & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCL
- FOR
- Stock Information
- Founded
- ABCL 2012
- FOR 2005
- Country
- ABCL Canada
- FOR United States
- Employees
- ABCL N/A
- FOR N/A
- Industry
- ABCL Biotechnology: Pharmaceutical Preparations
- FOR Real Estate
- Sector
- ABCL Health Care
- FOR Finance
- Exchange
- ABCL Nasdaq
- FOR Nasdaq
- Market Cap
- ABCL 1.1B
- FOR 1.0B
- IPO Year
- ABCL 2020
- FOR 2007
- Fundamental
- Price
- ABCL $4.01
- FOR $22.76
- Analyst Decision
- ABCL Strong Buy
- FOR Strong Buy
- Analyst Count
- ABCL 5
- FOR 3
- Target Price
- ABCL $7.50
- FOR $30.33
- AVG Volume (30 Days)
- ABCL 6.8M
- FOR 145.1K
- Earning Date
- ABCL 08-07-2025
- FOR 07-22-2025
- Dividend Yield
- ABCL N/A
- FOR N/A
- EPS Growth
- ABCL N/A
- FOR N/A
- EPS
- ABCL N/A
- FOR 3.29
- Revenue
- ABCL $23,114,000.00
- FOR $1,471,000,000.00
- Revenue This Year
- ABCL N/A
- FOR $3.95
- Revenue Next Year
- ABCL $67.99
- FOR $8.86
- P/E Ratio
- ABCL N/A
- FOR $6.91
- Revenue Growth
- ABCL N/A
- FOR N/A
- 52 Week Low
- ABCL $1.89
- FOR $18.00
- 52 Week High
- ABCL $4.33
- FOR $37.21
- Technical
- Relative Strength Index (RSI)
- ABCL 65.36
- FOR 68.80
- Support Level
- ABCL $3.28
- FOR $20.79
- Resistance Level
- ABCL $4.33
- FOR $23.18
- Average True Range (ATR)
- ABCL 0.30
- FOR 0.77
- MACD
- ABCL 0.02
- FOR 0.26
- Stochastic Oscillator
- ABCL 71.17
- FOR 90.31
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.